|Title:||5HT.sub.2C receptor modulators|
|Abstract:|| The present invention relates to novel compounds of Formula (I): ##STR00001## which act as 5HT.sub.2C receptor modulators. These compounds are useful in pharmaceutical compositions whose use includes the treatment of obesity.|
|Inventor(s):|| Smith; Jeffrey (San Diego, CA), Smith; Brian (San Diego, CA) |
|Assignee:|| Arena Pharmaceuticals, Inc. (San Diego, CA) |
|Filing Date:||Sep 14, 2012|
|Claims:||1. The compound that is N-trifluoroacetyl-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. |
2. The compound that is N-trifluoroacetyl-8-chloro-1-methylene-2,3,4,5-tetrahydro-1H-3-benzazepin- e.